Skip to main content
. 2018 Jun 8;9(44):27423–27434. doi: 10.18632/oncotarget.25384

Table 3. Multivariate Cox regression analysis and hazard models of independent factors influencing overall- and disease-free survival in the entire study cohort (UICC I-IV) and early tumour stages (UICC I+II).

overall survival disease-free survival
multivariate HR (95% CI) P multivariate HR (95% CI) P
UICC I-IV
CK20 < 2.77 vs ≥ 2.77 [EU] 2.49 (1.77 – 3.49) <0.001 2.34 (1.69 – 3.22) <0.001
age < 70 vs. ≥ 70 [years] 1.27 (0.90 – 1,79) 0.172 n.d.
UICC I+II vs. III+IV 7.85 (5.08 – 12.15) <0.001 7.39 (4.90 – 11.16) <0.001
adj. treatment yes vs. no 1.10 (0.77 – 1.56) 0.610 1.09 (0.78 – 1.53) 0.606
UICC I+II
CK20 < 2.77 vs. ≥ 2.77 [EU] 2.25 (1.06 – 4.77) 0.035 2.01 (1.01 – 4.01) 0.047
age < 70 vs. ≥ 70 [years] 1.59 (0.73 – 3.47) 0.245 n.d.
colon vs. rectum 0.22 (0.09 – 0.50) <0.001 0.27 (0.13 – 0.57) 0.001
pT1/2 vs. pT3/4 4.50 (1.99 – 10.17) <0.001 4.17 (1.97 – 8.85) <0.001

All P values in bold, are regarded as statistically significant; n.d.: the value was not significant in univariate analysis and therefore not considered in multivariate analysis; HR: hazard ratio, CI: confidence interval; CK20: cytokeratin 20; EU: expression units.